Cogent Biosciences, Inc.
USD39.58
+0.84 (+2.17%)
CEO
Andrew R. Robbins
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.84
Prev. Close
$38.74
Day Low
$38.15
Day High
$40.07
52W Low
$7.07
52W High
$43.73
Market Cap
$6.76B
Volume
2.19M
| -3.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -74.6% | -61.4% | 0.07 | 7.09 | -2.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -54.8% | -46.6% | 0.08 | 9.87 | -4.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -33.7% | -31.1% | 0.01 | 13.04 | -4.6 |
| 31 Dec 2020 | FY | -227.0% | -950.4% | -31.9% | -29.8% | 0.02 | 18.70 | -1.7 |
| 31 Dec 2019 | FY | 99.8% | -134.6% | -95.3% | -61.3% | 0.19 | 3.06 | -0.7 |
| 31 Dec 2018 | FY | 100.0% | -354.8% | -57.3% | -40.2% | 0.00 | 3.25 | -3.2 |
| 31 Dec 2017 | FY | 100.0% | -304.9% | -90.1% | -51.9% | 0.00 | 3.79 | -12.9 |
| 31 Dec 2016 | FY | 100.0% | -285.2% | -34.6% | -24.0% | 0.00 | 7.98 | -14.4 |
| -5.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -26.8% | -19.0% | 0.20 | 6.38 | -5.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -47.4% | -26.8% | 0.39 | 4.19 | -2.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -32.9% | -25.4% | 0.08 | 5.13 | -2.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -26.5% | -20.7% | 0.07 | 5.32 | -3.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -22.4% | -18.4% | 0.06 | 6.44 | -4.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -15.8% | -13.7% | 0.05 | 9.25 | -3.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -13.8% | -12.3% | 0.04 | 12.05 | -2.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -21.1% | -17.3% | 0.07 | 7.09 | -2.3 |